| ACEF | Age, Creatinine, Ejection Fraction |
| ACS | Acute Coronary Syndrome |
| AF | Atrial Fibrillation |
| AMI | Acute Myocardial Infarction |
| ASA | Acetylsalicylic Acid (Aspirin) |
| AUC | Area Under the Curve |
| CABG | Coronary Artery Bypass Grafting |
| CHA2DS2-VASc | Congestive Heart Failure, Hypertension, Age ≥ 75, Diabetes, Stroke/TIA/Thromboembolism, Vascular Disease, Age 65–74, Sex Category (Female) |
| CI | Confidence Interval |
| CICU | Coronary Intensive Care Unit |
| COVID-19 | Coronavirus Disease 2019 |
| CSS | Clinical SYNTAX score |
| DAPT | Dual Antiplatelet Therapy |
| DM | Diabetes Mellitus |
| ECG | Electrocardiography |
| EF | Ejection Fraction |
| GRACE | Global Registry of Acute Coronary Events |
| HDL | High-Density Lipoprotein |
| CrCl | Creatinine Clearance (Cockcroft–Gault) |
| HbA1c | Hemoglobin A1c |
| HR | Hazard Ratio |
| HT | Hypertension |
| IQR | Interquartile Range |
| LA | Left Atrium |
| LDL | Low-Density Lipoprotein |
| LVDD | Left Ventricular Diastolic Dysfunction |
| MACE | Major Adverse Cardiovascular Event |
| MI | Myocardial Infarction |
| NSTEMI | Non-ST-Elevation Myocardial Infarction |
| NOAF | New-Onset Atrial Fibrillation |
| NOAC | Non-Vitamin K Oral Anticoagulant |
| OAC | Oral Anticoagulation |
| OACIS | Osaka Acute Coronary Insufficiency Study |
| OR | Odds Ratio |
| PCI | Percutaneous Coronary Intervention |
| RAAS | Renin-Angiotensin-Aldosterone System |
| ROC | Receiver Operating Characteristic |
| SD | Standard Deviation |
| SIRTAX | Sirolimus-Eluting Stent Compared with Paclitaxel-Eluting Stent for Coronary Revascularization |
| SS | SYNTAX Score |
| STEMI | ST-Elevation Myocardial Infarction |
| SYNTAX | Synergy Between PCI With Taxus and Cardiac Surgery |
| TAT | Triple Antithrombotic Therapy |
| TIA | Transient Ischemic Attack |
| VIF | Variance Inflation Factor |